Swiss Re AG
XBER:SR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swiss Re AG
XBER:SR9
|
CH |
|
F
|
Fluor Corp
XBER:FLU
|
US |
|
A
|
Aflac Inc
XBER:AFL
|
US |
|
A
|
Apogee Enterprises Inc
F:ANP
|
US |
|
F
|
Fresenius SE & Co KGaA
LSE:0OO9
|
DE |
|
Sands China Ltd
OTC:SCHYY
|
MO |
|
Olam Group Ltd
SGX:VC2
|
SG |
|
S
|
Sonoco Products Co
F:SNS
|
US |
|
F
|
Fuji Electric Co Ltd
OTC:FELTY
|
JP |
|
P
|
Philip Morris International Inc
XMUN:4I1
|
US |
|
W
|
Willis Towers Watson PLC
XBER:WTY
|
UK |
|
TAL Education Group
NYSE:TAL
|
CN |
|
P
|
Pioneer Natural Resources Co
LSE:0KIX
|
US |
|
Endesa SA
MAD:ELE
|
ES |
Discount Rate
SR9 Cost of Equity
Discount Rate
SR9's Cost of Equity, calculated using the formula Risk-Free Rate + Beta x ERP, stands at 7.6%. The Beta, indicating the stock's volatility relative to the market, is 0.76, while the current Risk-Free Rate, based on government bond yields, is 4.42%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
What is SR9's discount rate?
SR9's current Cost of Equity is 7.6%.
In the valuation of banks and insurance companies, only the cost of equity is used due to their unique capital structures and regulatory environments.
These institutions heavily rely on debt, regulated more stringently than other industries, making the Weighted Average Cost of Capital (WACC) less applicable and accurate for them. The cost of equity offers a more direct measure of the risk and return expectations relevant to these specific sectors.
How is Cost of Equity for SR9 calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
SR9